Pharmacologic treatment of cardiac arrest
- PMID: 10534025
- DOI: 10.1080/10903129908958954
Pharmacologic treatment of cardiac arrest
Abstract
Antiarrhythmic drugs currently recommended in the American Heart Association's Advanced Cardiac Life Support (ACLS) guidelines for the treatment of cardiac arrest have not been proved in controlled clinical trials to improve survival in patients with ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT). Intravenous amiodarone is a promising agent for the treatment of VF and VT. Based on available evidence, amiodarone should be considered for use in patients with shock-refractory ventricular arrhythmias.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical